home / stock / akblf / akblf short
Short Information | Alk-Abello A/S (OTCMKTS:AKBLF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 16,685 |
Total Actual Volume | 23,986 |
Short Trends | |
---|---|
Cover Days | 1 |
Short Days | 19 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 834 |
Average Short Percentage | 90.17% |
Is there a AKBLF Short Squeeze or Breakout about to happen?
See the AKBLF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-01-2024 | $22.08 | $21.72 | $22.08 | $21.72 | 2 | 1 | 50% |
06-04-2024 | $21.165 | $21.165 | $21.165 | $21.165 | 10 | 10 | 100% |
06-03-2024 | $23 | $22.5 | $23 | $22.5 | 185 | 185 | 100% |
05-30-2024 | $22.5 | $22.5 | $22.5 | $22.5 | 2,800 | 2,800 | 100% |
05-06-2024 | $22.45 | $22.45 | $22.45 | $22.45 | 1 | 1 | 100% |
04-19-2024 | $17.9 | $17.9 | $17.9 | $17.9 | 19 | 19 | 100% |
03-27-2024 | $18.4 | $18.4 | $18.4 | $18.4 | 633 | 633 | 100% |
02-20-2024 | $19.9 | $18.5 | $19.9 | $18.5 | 3,000 | 1,500 | 50% |
02-08-2024 | $17.31 | $17.31 | $17.31 | $17.31 | 40 | 40 | 100% |
01-12-2024 | $0 | $13.25 | $0 | $0 | 575 | 575 | 100% |
01-11-2024 | $0 | $13.25 | $0 | $0 | 4,196 | 4,196 | 100% |
10-23-2023 | $11 | $11 | $11 | $11 | 100 | 100 | 100% |
08-28-2023 | $12.3 | $12.3 | $12.3 | $12.3 | 452 | 452 | 100% |
08-21-2023 | $11.05 | $11.05 | $11.05 | $11.05 | 10 | 10 | 100% |
08-11-2023 | $11.35 | $11.35 | $11.35 | $11.35 | 700 | 700 | 100% |
07-07-2023 | $11.2 | $8.7 | $11.2 | $8.2 | 6,002 | 202 | 3.37% |
06-01-2023 | $0 | $12.06 | $0 | $0 | 1 | 1 | 100% |
04-12-2023 | $14 | $14 | $14 | $14 | 250 | 250 | 100% |
11-11-2022 | $14.9 | $14.9 | $14.9 | $14.9 | 10 | 10 | 100% |
11-04-2022 | $0 | $16.23 | $0 | $0 | 5,000 | 5,000 | 100% |
News, Short Squeeze, Breakout and More Instantly...
Alk-Abello A/S Company Name:
AKBLF Stock Symbol:
OTCMKTS Market:
ALK ( ALKB:DC / OMX: ALK B / AKBLF ) today announced that the Board of Directors has adopted a new corporate strategy (Allergy + ) and 2028 financial ambitions. Allergy + aims to further strengthen ALK’s leadership in allergy immunotherapy, establishing a leading position...
Company release No. 11/2024 ALK delivers 10 % organic revenue growth with operating profit up 41 % in Q1 and upgrades outlook The growth in ALK's overall sales was primarily driven by the European tablet sales, which were boosted by the inflow of new patients and improved ...
ALK ( ALKB:DC / OMX: ALK B / AKBLF ): The Annual General Meeting of ALK-Abelló A/S will take place on Thursday, 14 March 2024 at 4:00 PM (CET) at ALK-Abelló A/S, 1 Bøge Allé, 2970 Hørsholm, Denmark. The agenda of the meeting including the complete proposals from the B...